Evidence map›Paper›PMID 28539656›Full record

ArticleScientific reports2017

PKC-δ isoform plays a crucial role in Tat-TLR4 signalling pathway to activate NF-κB and CXCL8 production.

Manutea Serrero, Rémi Planès, Elmostafa Bahraoui

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. HOxidative medicine and cellular longevity · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Manutea SerreroCPTP, U1043, INSERM/CNRS/UPS, Toulouse, France.
Rémi PlanèsCPTP, U1043, INSERM/CNRS/UPS, Toulouse, France.
Elmostafa BahraouiCPTP, U1043, INSERM/CNRS/UPS, Toulouse, France. bahraoui@cict.fr.
Centre National de la Recherche Scientifique · FRInserm · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 Tat protein induces the production of CXCL8 chemokine in a TLR4/MD2 and PKC dependent manner. The objective of this study was to understand whether these two pathways were distinct or constituted a single common pathway, and to determine the nature of the PKC isoforms involved and their interrelation with the activation of NF-κB and CXCL8 gene product expression. Here, we show that Tat-induced CXCL8 production is essentially dependent on the activation of PKC delta isoform, as shown a) by the capacity of PKC delta dominant negative (DN), and Rottlerin, a selective PKC delta pharmacological inhibitor, to inhibit Tat-induced CXCL8 production and b) by the ability of the constitutively active (CAT) isoform of PKC delta to induce CXCL8 production in a HEK cell line in the absence of Tat stimulation. The finding that comparable amounts of CXCL8 were produced following stimulation with either Tat protein, PKC-delta CAT transfection, or both, argue for the implication of one common pathway where PKC delta is activated downstream of TLR4 recruitment and leads to the activation of NF-κB. Altogether, our results underline the crucial role of PKC delta isoform in activating gene expression of CXCL8, a cytokine largely implicated in the physiopathology of HIV-1 infection.

Indexed as

AcetophenonesBenzopyransEnzyme InhibitorsGene Expression RegulationGlutathione TransferaseHEK293 CellsHumansInterleukin-8IsoenzymesMonocytesNF-kappa BPlasmidsPrimary Cell CultureProtein Kinase C betaProtein Kinase C-deltaRecombinant Fusion ProteinsAcetophenonesBenzopyransCXCL8 protein, humanEnzyme InhibitorsGlutathione TransferaseInterleukin-8IsoenzymesNF-kappa BProtein Kinase C betaProtein Kinase C-deltaRecombinant Fusion Proteinsrottlerintat Gene Products, Human Immunodeficiency VirusTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID28539656
PMCPMC5443767
OpenAlexW2614109391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.